A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Beyond Air, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 20,975 shares of XAIR stock, worth $8,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,975
Previous 87,568 76.05%
Holding current value
$8,809
Previous $47.1 Million 82.7%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.36 - $0.64 $23,973 - $42,619
-66,593 Reduced 76.05%
20,975 $8.14 Million
Q2 2024

Aug 14, 2024

BUY
$0.54 - $1.67 $47,286 - $146,238
87,568 New
87,568 $47.1 Million

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $12.6M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.